Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.299NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.149NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.300NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.179NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.125NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
G.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.438NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.178NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.208NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.197NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.491NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.8 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.39.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BY.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.424NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.64NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.327NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.396NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.129NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.221.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.224NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.618NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.458NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
W.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.264.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.190NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.552NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used